Biogen

A summary of daily Biopharma industry news. Please check out stories that are trending on March 20, 2020.

Approximately 100 cases of COVID-19 have been linked to a Biogen corporate meeting, as reported by a local media station in the Boston area.

As the number of diagnosed cases of COVID-19 continue to increase across the globe and more and more governments are urging citizens to self-quarantine, the pharmaceutical and life sciences industry continues to work toward the development of a vaccine and therapies for the respiratory infection that was declared a pandemic by the World Health Organization last week. Here’s a biopharma industry overview as of late March 16.

Numerous organizations are cancelling or postponing activities that involve large groups of people.

According to reports, 15 employees who attended a management meeting in Boston have now tested positive for the virus.

According to a company statement, the three employees are doing well and “improving under the care of their healthcare providers.”

Ghosh succeeds current Unity CEO Keith Leonard, who will step down from his role. Leonard will continue as the chairman of the board of directors.

Biogen and Sangamo Therapeutics announced a broad global licensing collaboration deal to develop and commercialize several compounds for a range of neurological and neuromuscular diseases.

The most recent BioSpace Ideal Employer Report revealed the impact of team dynamics on employees within life sciences organizations.